The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Bristol-Myers Squibb; EUSA Pharma; Ipsen; Janssen; Pfizer
A randomized phase II study of nivolumab plus ipilimumab versus standard of care in previously untreated and advanced non-clear cell renal cell carcinoma (SUNIFORECAST).
 
Marit Ahrens
No Relationships to Disclose
 
Bernard Escudier
Honoraria - Bristol-Myers Squibb; EUSA Pharma; Ipsen; Novartis; Oncorena; Pfizer; Roche/Genentech
Consulting or Advisory Role - AVEO; Bristol-Myers Squibb; EUSA Pharma; Ipsen; Novartis; Pfizer; Roche/Genentech
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; MSD; Pfizer; Roche/Genentech
 
Ekaterini Boleti
No Relationships to Disclose
 
Marc-Oliver Grimm
Honoraria - Apogepha; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Medac; MSD; Novartis; Ono Pharmaceutical; Pfizer
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer Health; Bristol-Myers Squibb; Hexal; Intuitive Surgical; Ipsen; Janssen; Merck; MSD; Novartis; Ono Pharmaceutical; Pfizer; Roche
Research Funding - Bristol-Myers Squibb (Inst); Intuitive Surgical (Inst)
Travel, Accommodations, Expenses - Bayer Health; Bristol-Myers Squibb; Merck Serono
 
Marine Gross-Goupil
Consulting or Advisory Role - Amgen; Astellas Medivation; AstraZeneca; Bayer/Onyx; Bristol-Myers Squibb; ipsen; Janssen-Cilag; MSD Oncology; Pfizer; Roche; Sanofi
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); ipsen (Inst); Janssen-Cilag (Inst); Merck (Inst); MSD Oncology (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; AstraZeneca; ipsen; MSD Oncology; Roche; Roche; Roche
 
Philippe Barthelemy
Honoraria - Astellas Pharma; EUSA Pharma
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Janssen-Cilag; MSD Oncology; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Amgen
 
Gwenaelle Gravis
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Ipsen; Janssen Oncology; Pfizer; Sanofi
 
Jens Bedke
No Relationships to Disclose
 
Philipp Ivanyi
No Relationships to Disclose
 
Andrej Panic
No Relationships to Disclose
 
Stefanie Zschaebitz
No Relationships to Disclose
 
Sylvie Negrier
Honoraria - Bristol-Myers Squibb; EUSA Pharma; Ipsen; MSD Oncology; Novartis; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; EUSA Pharma; Ipsen; Novartis; Pfizer
Research Funding - IPSEN (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; EUSA PHARMA; IPSEN; Novartis; Pfizer
 
Begona Mellado
No Relationships to Disclose
 
Anika Biel
No Relationships to Disclose
 
Tom Waddell
No Relationships to Disclose
 
Pablo Maroto
No Relationships to Disclose
 
Margitta Retz
No Relationships to Disclose
 
Martin Boegemann
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer/Vital; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Janssen-Cilag; Merck; MSD; Novartis; Pfizer; Roche; Sanofi/Aventis
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; ipsen; Janssen-Cilag; Merck; MSD; Novartis; Roche; Sanofi
Research Funding - Janssen-Cilag
Travel, Accommodations, Expenses - Amgen; Bayer; Janssen-Cilag
 
Arndt Hartmann
Honoraria - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; MSD; Roche
Consulting or Advisory Role - 3DHISTECH; AstraZeneca; Bristol-Myers Squibb; Cepheid; Diaceutics; Illumina; Ipsen; Janssen-Cilag; MSD; NanoString Technologies; Qiagen; Roche
Research Funding - AstraZeneca; BioNTech; Cepheid; Janssen-Cilag; NanoString Technologies; Roche
Expert Testimony - NanoString Technologies
 
Lothar Bergmann
Consulting or Advisory Role - Bristol-Myers Squibb; EUSA Pharma; Ipsen; Pfizer
Research Funding - Bristol-Myers Squibb (Inst)